Research Studies
One of our Latinos United for Cancer Health Advancement (LUCHA) goals is to increase Latino participation in cancer preventative screenings and studying cancer in humans, also referred to as clinical trials. Latinos are currently underrepresented in these important studies, leaving this population behind in the fight to reduce the cases of cancer. Below you will find descriptions of studies being led by the LUCHA research team in which you may qualify to participate:
Current Studies For Participation
- This study seeks to understand the needs in the Latino community to increase participation in cancer screening and human studies, and cancer prevention education and options, in the 19 counties we serve.
- Eligibility: (1) of Hispanic/Latino ethnicity, (2) 18 years or older (3) and live within the 19 county UC Davis Comprehensive Cancer Center catchment area.
- ClinicalTrials.gov ID: NCT04314752
- This study seeks to better understand the causes of multiple myeloma, survival, and to develop race-appropriate models for identifying and addressing causes of multiple myeloma.
- Eligibility: If you were (1) diagnosed with Multiple Myeloma within the previous 5 years, (2) at least 21 years of age at diagnosis (3) and, if you are of African American, Latino, Asian American/Native Hawaiian/Pacific Islander or White race or ethnicity.
If you meet the above requirements and are interested in participating or if you have any other questions, please contact the LUCHA research team here, or call 916-734-4563.
Tu Historia Cuenta (Hereditary Breast Cancer Study)
- This study aims to educate and assesses risk for hereditary breast cancer in the Spanish speaking Latino community. This Education program is conducted by promotores to provide the hereditary breast cancer education curricula in Los Angeles, San Francisco and Sacramento area.
If you would like to hear more about this program, please contact: Fabian Perez at fpperez@ucdavis.edu
A Longitudinal Study on Pre-Malignant Gastric Conditions (Intestinal Metaplasia Study)
- ClinicalTrials.gov ID: NCT05021029
- This study aims to better understand the development of intestinal metaplasia.
- Eligibility to participate: (1) if you have been diagnosed within the last 5 years or suspected of having with Intestinal metaplasia, chronic gastritis, atrophic gastritis, intestinal, (2) patient at UC Davis Medical Health Center, (3) over the age of 18, (4) of any race or ethnicity
If you meet the above requirements and are interested in participating or if you have any other questions, please contact the LUCHA research team here, or call 916-734-4563.
Latin America Genomics of Breast Cancer Consortium (LAGENO-BC)
The LAGENO-BC consortium is a collaborative effort including a multinational team of investigators sharing knowledge and materials to facilitate breast cancer genetics research relevant to the diverse populations of Latin America and its diaspora. LAGENO-BC aims to build a large research resource of genome wide genotype data including individuals from different countries and genetic ancestry proportions to study the Latin America-specific genetic architecture of breast cancer risk and survival. If you are a researcher who is interested in joining the consortium or would like more information like accessing our data, please contact the LAGENO-BC manager Fabian Perez at fpperez@ucdavis.edu
*Estudios disponibles en ingles y español